Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health, Inc. operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method to reserve accounts, leading to inflated receivable reports [4]. Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the case caption Postiwala v. Ardent Health, Inc., et al. [3].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码： 000919 证券简称：金陵药业 公告编号：2026-007 金陵药业股份有限公司 关于子公司补缴税款的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、基本情况 金陵药业股份有限公司（以下简称"公司"）控股子公司南京鼓楼医院集团宿迁医院有限公司（以下简 称"宿迁医院"）近日收到国家税务总局宿迁市税务局稽查局的税务处理决定书，根据税务机关的要求， 宿迁医院需补缴2022年至2024年期间的税款及滞纳金841.15万元。截止本公告日，上述税款及滞纳金已 经全部缴纳，本次不涉及行政处罚。 二、对公司的影响 根据《企业会计准则第28号一会计政策、会计估计变更和差错更正》相关规定，上述补缴税款事项不属 于前期会计差错，不涉及前期财务数据追溯调整。上述缴纳的税款及滞纳金计入公司2025年当期损益， 对公司2025年度归属于上市公司股东的净利润的具体影响最终以2025年度经审计的财务报表为准。本事 项不会对公司生产经营产生重大影响，敬请广大投资者注意投资风险。 特此公告。 金陵药业股份有限公司董事会 2 ...

Core Viewpoint - Tenet Healthcare Corporation (NYSE: THC) is experiencing significant stock performance improvements following a strong earnings report, with analysts projecting further growth potential. Group 1: Stock Performance - Tenet Healthcare's stock increased by 11.8%, reaching a high of $216.04 after the earnings report [2][5] - The current trading price of THC is $226.35, reflecting a 17.26% increase or $33.31 [4] - The stock has fluctuated between a low of $186.50 and a high of $229 today, with $229 being the highest price over the past year [4] Group 2: Financial Performance - The company's earnings report revealed an EPS of $4.70 for the quarter, surpassing analysts' consensus estimates of $4.05 by $0.65 [3][5] - Tenet Healthcare achieved a net margin of 6.49% and a return on equity of 25.11% [3] - Revenue increased by 8.9% compared to the same quarter last year, indicating strong financial health [3] Group 3: Analyst Projections - RBC Capital set a new price target of $277 for THC, suggesting a potential 22.38% increase from its current price [1][5]

2026年2月15日至23日春节假期，重庆多家三甲医院门诊时间分科、分院区调整，部分科室上午应诊、 部分时段停诊。其中市中医院、重医附属儿童医院正常应诊，各医院急诊科均照常接诊。此次调整覆盖 综合三甲、妇幼、肿瘤、中医等各类医院，明确分科出诊时间，方便市民假期合理安排就医，保障春节 诊疗需求。 假期看诊总时间 ①本次门诊调整覆盖2月15日至2月23日春节全假期 ②各医院急诊科全年无休、照常接诊 ③市中医院、重医附属儿童医院全程正常应诊 ①院本部：血液净化中心2月15日至23日全天应诊，多科室分时段上午/全天出诊 ②三院院区：康复、老年护理门诊2月15日至23日全天应诊 ③中山院区：耳鼻喉科、眼科、口腔科2月19日至23日全天应诊 ④各专科均按具体日期上午/全天分时段开放 西南医院/新桥医院/大坪医院 重医附一院门诊安排 ①2月15日：上午应诊 ②2月16日至18日：全天停诊 ③2月19日至22日：上午应诊 ④2月23日：全天应诊 重庆市人民医院（三院区） 急救医疗中心&肿瘤医院 ①市急救医疗中心：心内科、神内科等2月15至23日上午应诊，多个科室全天应诊 ①西南医院：2月15日至18日停诊，2月19日至20日 ...

转自：四川在线 年味渐浓，团圆正当时，健康守护少不了。春节假期里，若突发不适需要就诊，或是慢性病患者需续药复查，不少人可能会问：医院放假了吗？ 能正常做检查吗？别担心，"健康科代表"综合梳理了四川部分医院假期的排班时间。一起来看，以备不时之需。 1、四川大学华西医院 2、四川大学华西口腔医院 2026年春节期间（2月15日—2月19日），门诊停诊五天，在此期间急诊正常开诊。2月20日起，门诊正常开诊，实行非急诊全预约挂号，请患者朋 友提前通过官方微信服务号进行预约挂号。 3、四川大学华西第四医院 2月15日（腊月二十八）至2月19日（初三）门诊停诊。2月20日至2月28日，按门诊安排出诊。 温馨提示：就诊前请通过官方渠道查询最新门诊安排 4、四川大学华西天府医院 2月16日（除夕）至2月19日（初三）门诊停诊4天。周六、周天门诊暂未开放。门诊停诊期间，急诊照常运行。 门诊停诊期间，门诊采血及门诊相关辅助检查科室均暂停。 5、四川省人民医院 2026年2月16日（星期一，除夕）、2月17日（星期二，初一）、2月18日（星期三，初二）、2月19日（星期四，初三）门诊、采血及检查科室 （包括主院区、温江院区、锦江院 ...

Group 1 - The article highlights that many hospitals in Changsha will remain operational during the Spring Festival, ensuring continuous medical services for the public [1] - Emergency departments and fever clinics will operate 24 hours a day throughout the holiday period [3][12] - A total of 28 hospitals in Changsha have provided their schedules for outpatient and emergency services during the 2026 Spring Festival [1] Group 2 - Central South University Xiangya Hospital will have normal operations on February 14 and will open holiday outpatient services on February 15 [2] - Xiangya Second Hospital will have emergency services open during the holiday, with outpatient services resuming on February 20 [4][5] - Xiangya Third Hospital will also follow a similar schedule, with outpatient services closed from February 15 to 19 and reopening on February 20 [6] Group 3 - Hunan Provincial People's Hospital will close outpatient services from February 16 to 19, but emergency services will remain open 24 hours [7][8] - Hunan Provincial Tumor Hospital will be closed for outpatient services from February 15 to 21, with normal operations resuming on February 22 [10] - Hunan Provincial Children's Hospital will maintain 24-hour emergency services and regular outpatient services during the holiday [11] Group 4 - Hunan Chest Hospital will operate as a "no-holiday hospital," ensuring that both outpatient and emergency services are available during the Spring Festival [13] - Hunan Occupational Disease Prevention Hospital will have specific outpatient services available on certain days, while emergency services will be open 24 hours [14] - Hunan University Affiliated Changsha Hospital will also ensure that emergency and fever clinics are operational 24 hours during the holiday [38]

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method that inflated reported accounts receivable and delayed loss recognition [4]. Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3].

济宁市妇幼保健院党委书记陈玉清介绍市康复医院建设情况，市残联党组书记、理事长李朋与市卫生健康委党组书记、主任张公迁共同为市康复医院揭 牌。启动仪式结束后，与会人员参观了医院。 王庆在讲话中指出，市康复医院的建成投用，是济宁市健全公共卫生服务体系、优化医疗资源布局的重要举措，填补了济宁市公立康复机构的空白。医院 要瞄准打造鲁西南康复医学中心这一目标，坚持以学科建设为核心，加强与高水平医疗机构的交流合作，注重"预防、治疗、康复"三位一体发展，快速提 升诊疗技术和服务能力，建设成为政府放心、社会认可、群众满意的现代化康复医院。 齐鲁晚报.齐鲁壹点郭纪轩通讯员田国栋 2月11日，济宁市康复医院正式启用。济宁市政府副市长王庆出席启动仪式并宣布市康复医院正式启用。 市直相关部门负责同志，市直及省属驻济卫生健康单位主要负责同志、医院医护团队及媒体记者约70人参加活动。 ...

分组1 - The Federal Reserve paused interest rate changes to assess the impact of higher borrowing costs on inflation and the economy, maintaining the funds rate at 5.25% to 5.50% since September 2023 [1][2] - The dual mandate of the Fed requires balancing inflation control and job growth, with recent job market data complicating expectations for future rate cuts [2][20] - The January jobs report showed unexpected job growth, with payrolls rising by 130,000, leading to a decrease in the unemployment rate from 4.4% to 4.3%, indicating a resilient labor market [4][5][18] 分组2 - The health care sector led job gains in January, adding 82,000 positions, while other sectors like social assistance and construction also saw growth [7][8] - Economists expect inflation to ease, with projections of a more subdued Consumer Price Index (CPI) reading, suggesting potential room for rate cuts to support labor market recovery [17][20] - Fed officials are cautious about further rate cuts, emphasizing the need to monitor inflation trends and labor market stability before making decisions [21][24][25]

Core Insights - Tenet Healthcare Corporation reported fourth-quarter sales of $5.527 billion, an increase of approximately 8.9% year over year, surpassing the consensus estimate of $5.472 billion [1] - Adjusted earnings per share rose to $4.70 from $3.44 a year ago, exceeding the consensus of $4.05 [1] Financial Performance - Adjusted EBITDA for the fourth quarter was $1.183 billion, up from $1.048 billion a year ago, reflecting strong growth in same-facility revenue, higher acuity, and disciplined expense management [2] - Hospital Operations and Services revenues increased by 7.3% to $4.09 billion, driven by a favorable payer mix, higher acuity, and increased Medicaid supplemental revenues [4] Segment Breakdown - Ambulatory segment revenues rose by 13.8% to $1.43 billion, supported by strong growth in same-facility net patient services revenues, facility acquisitions, and expanded service lines [3] - Surgical business same-facility system-wide net patient service revenues increased by 7.2%, with cases up by 1.6% and net revenue per case up by 5.5%, driven by higher acuity and a favorable payer mix [3] Management Commentary - The CEO of Tenet highlighted the company's strong revenue growth, disciplined operations, improved margins, and robust free cash flow generation in 2025 [5] Outlook - For 2026, Tenet expects revenue guidance between $21.5 billion and $22.3 billion, compared to the consensus of $22.21 billion [6] - The guidance includes Hospital segment sales of $16 billion to $16.6 billion and Ambulatory Segment sales of $5.5 billion to $5.7 billion [7] - Adjusted earnings are forecasted to be between $16.19 and $18.47, with adjusted EBITDA expected in the range of $4.485 billion to $4.785 billion [7] Stock Performance - Tenet shares increased by 6.73% to $206.03 at the time of publication, with a daily high of $206.08 and a low of $186.50, currently 7.5% below its 52-week high [8]